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Abstract
Fitness trackers are devices or applications for monitoring and tracking fitness-related met-
rics such as distance walked or run, calorie consumption, quality of sleep and heart rate.
Since accurate heart rate monitoring is essential in fitness training, the objective of this
study was to assess the accuracy and precision of the Fitbit Charge 2 for measuring heart
rate with respect to a gold standard electrocardiograph. Fifteen healthy participants were
asked to ride a stationary bike for 10 minutes and their heart rate was simultaneously
recorded from each device. Results showed that the Fitbit Charge 2 underestimates the
heart rate. Although the mean bias in measuring heart rate was a modest -5.9 bpm (95% CI:
-6.1 to -5.6 bpm), the limits of agreement, which indicate the precision of individual measure-
ments, between the Fitbit Charge 2 and criterion measure were wide (+16.8 to -28.5 bpm)
indicating that an individual heart rate measure could plausibly be underestimated by almost
30 bpm.
Introduction
Fitness trackers, also referred to as activity trackers, activity monitors or fitness bands are
devices or applications for monitoring and tracking fitness-related metrics such as distance
walked or run, calories consumed, and heart rate. The World Health Organization (WHO)
recommends that adults aged 18–64 should do at least 150 minutes per week of moderate-
intensity aerobic physical activity or at least 75 minutes of vigorous-intensity aerobic physical
activity throughout the week (or a combination of both) to reduce the risk of chronic diseases
and depression. Fitness trackers provide an easy interface for adults to meet those guidelines
and, according to IDC worldwide quarterly device tracker, over 100 million units were sold in
2016. Fitness trackers, as the name suggests, have been conceived and marketed for tracking
fitness related activities but, thanks to the continuous advancements in wearable technology,
the potential applications have also expanded to include medical surveillance, non-invasive
medical care, and mobile health-wellness monitoring [1, 2, 3].
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Even if the reliability of wrist-worn trackers in clinical settings is still under debate, their
adoption in human physiology research has been unanimously accepted in the last 2 years [1].
Consumer activity monitors, such as Fitbit, Apple watch, Jawbone, Microsoft band, to name a
few, are now widely used in biomedical research to study therapeutic effects of self-monitor-
ing, exercise therapy and behavioral interventions. An intense area of research aims at
estimating the association between physical activity and metabolic function, cognitive and
neurological health using consumer activity trackers. Also, interventional studies employed fit-
ness trackers to improve the quality of life of breast cancer patients [https://clinicaltrials.gov/
ct2/show/NCT02637765], and those who are giving up smoking [https://clinicaltrials.gov/ct2/
show/NCT02422914]. The adoption of physical monitoring devices allowed scientists to iden-
tify specific biomarkers to predict lung function in young adults with asthma [NCT02556567]
or surgical complications after abdominal cancer surgery [NCT02356471]. Finally, interven-
tional studies support the value of wearable activity trackers as motivational tool for specific
patients (e.g. for weight management in childhood obesity, diabetes, cystic fibrosis in adoles-
cents, recovering alcoholics, peripheral artery disease, and knee osteoarthritis) and thus as a
key factor for disease prevention and management.
Accurate and precise self-monitoring devices therefore provide potential benefit both to the
patient, by providing real-time feedback on his specific physiological status, and to the health
care provider, since they can collect and present a full set of information, including activity fre-
quency, duration, and intensity, heart rate (HR), and energy consumption.
A key metric measured by fitness trackers is HR, namely the number of contractions of the
heart per minute (bpm). Physical exercise, sleep, anxiety, stress, illness, and ingestion of drugs
are all factors known to alter the normal HR and therefore HR has been used as an indicator of
physiological adaptation and intensity of effort [4]. According to Takacs et al. [5], inaccurate
measures of physical activity levels can affect the ability to monitor health status. Therefore,
accurate HR monitoring is essential in fitness training and testing. Methods used to detect
changes in HR include: electrocardiogram (ECG), blood pressure, ballistocardiograms and the
pulse wave signal derived from a photoplethysmogram (PPG).
Recently, the need for affordable, simple and portable technology for both the primary care
and community based clinical settings, together with the wide availability of low cost and
small semiconductor components, have raised attention around PPG [6]. PPG is an optical
measurement technique that measures the amount of backscattered infrared light through a
tissue to assess the variation of blood volume and thus the heart rate [7]. According to Murthy
et al. [8], photoplethysmography is a simple, reliable and low-cost optical technique for mea-
suring changes in blood volume in the microvascular bed of tissue. Recent studies suggest this
method has acceptable validity [9], although the accuracy is often dependent on the device
used, the type and intensity of activity, and skin photosensitivity [10,11,12].
All wrist worn activity trackers rely on PPG and use proprietary HR-derived algorithms
and several recent studies investigated the accuracy of wearable devices for measuring HR
[10,13,14,15,16,17,18,19,20,21,22]. Here, we critically assessed the accuracy of the Fitbit Charge
2 (Fitbit Inc., San Francisco, CA) with respect to HR monitoring and compared its perfor-
mance to a gold standard electrocardiograph. The Fitbit Charge 2 monitors HR activity—
through a patented PPG technology called PurePulse—counts steps, calories burned and tracks
sleep activity. Based on the manufacturer’s information, Fitbit uses PurePulse light-emitting
diodes on the skin-facing surface monitor blood volume changes to continuously estimate HR
[23]. In the past 2 years, several studies have been published on the most recent predecessor of
this device, the Charge HR [10,13,14,16,17,18,20,21]. The large majority of these studies
yielded similar results (i.e. aggregate mean biases between -2.5 bpm [21] and -9.3 bpm [10]).
Since no studies have been published so far on the Charge 2, the purpose of our study was to
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evaluate for the first time the accuracy of this device for measuring HR with respect to an ECG
criterion measure.
Materials and methods
The accuracy of the Fitbit Charge 2 for measuring HR was assessed with respect to an ECG cri-
terion measure (ProComp Infiniti T7500M). The ProComp Infiniti T7500M, is an 8 channel
multi-modality encoder for real-time, computerized biofeedback and data acquisition in clini-
cal setting (Thought Technology LTD, Toronto, CANADA). For ECG recording, the electrode
placement sites were prepared by standardized procedures of cleaning, shaving, and abrading
the skin to improve signal acquisition and to minimize noise artifact. Three silver/silver-chlo-
ride self-adhesive electrodes (RA, RL, LA) were placed on the upper torso. HR data per second
was converted to beats per minute (bpm) automatically by the data acquisition software pro-
gram prior to analysis. The Fitbit Charge 2 was placed on the non-dominant wrist following
manufacturer instructions and was charged fully prior to testing.
Fifteen Caucasian participants (8 females, 7 males) took part in the experiment. Table 1
shows means, standard deviations (SD) and ranges for age, weight, height, and Body Mass
Index (BMI). All participants gave written informed consent before participation. We
excluded participants with neurological or cognitive disorders, recent musculoskeletal damage
or surgery that would impair motor function, and tattoos. The study was performed in a con-
trolled experiment room at TSW XP Lab, Treviso—Italy (www.tsw.it) complying with the Dec-
laration of Helsinki. The TSW XP Lab Ethics Committee approved the study.
Participants were asked to ride a stationary bike with the stated goal to raise their HR as
much as possible, but they were free to slow down and rest at any time they desired to do so.
The goal of the experiment was not to evaluate the training activity but rather collecting
enough HR data spanning a range of BPMs as wide as possible. HR was simultaneously
acquired for 10 minutes using both devices (Fitbit Charge 2, ProComp Infiniti). Since at
the time the experiment was conducted, the Fitbit Charge 2 did not allow the download of sec-
ond-by-second HR data, HR information (i.e. bpm) provided by the official Fitbit app for
Android was displayed on a dedicated smartphone and then recorded via an HD camera
pointed towards the display. Second-by-second HR data was manually extracted from each
video and subsequently used for analysis. During each recording, the correspondence between
the information visualized on the app and on the Fitbit Charge 2 display was checked multiple
times to ensure the reliability of data collection and no discrepancies were found. Agreement
between the Fitbit device and the ECG gold standard was estimated using the Bland-Altman
method, adapted to take into account repeated measures from the same person when the true
value varies over time [24, 25]. This provided an estimate of agreement between the Fitbit and
ECG in the instantaneous value of the changing heart rate. We also modelled the relationship
between the paired differences and their average to assess the extent to which the agreement
Table 1. Age, weight, height, and BMI means and ranges.
Male Female
Mean (SD) Range Mean (SD) Range
Age (Years) 31 (4) 25 to 36 32 (4) 26 to 36
Weight (kg) 78 (3) 76 to 82 60 (3) 56 to 65
Height (cm) 180 (3) 175 to 185 165 (5) 155 to 175
BMI (kg/m2) 24 (0.65) 23 to 25 22 (1.22) 20 to 23
Standard deviations are presented in parentheses.
https://doi.org/10.1371/journal.pone.0192691.t001
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varied with heart rate, and estimated the intraclass correlation coefficient (ICC) as an alterna-
tive measure of agreement All statistical analyses were performed using Statsoft STATISTICA
10 and StataCorp Stata 15.1.
Results
The dataset consisted of 9000 seconds of data (10 min x 15 participants). However, since the
Charge 2 produced several disruptions to continuous HR detection, the dataset was reduced
by around 10%. Fig 1. shows all time-synced ECG and Charge 2 HR ordered data in aggregate
while Table 2 shows the HR comparison data between Charge 2 and gold standard ECG.
The Charge 2 exhibited a mean bias of -5.9 bpm (95% CI: -6.1 to -5.6 bpm). As to the limits
of agreement (LoA) between the Fitbit Charge 2 and criterion measure the upper LoA was +17
bpm, whereas the lower LoA was -29 bpm (Fig 2). The ICC between Fitbit Charge 2 and gold
standard ECG was 0.21 (95% CI: 0.09 to 0.34). Furthermore, there was no evidence that the
extent of agreement varied much across the range of heart rates (see Fig 3).
Fig 1. Ordered HR data (Fitbit Charge 2 vs. ECG). Data have been ordered according to the frequencies collected by the criterion measure (ECG). (n = 9000).
https://doi.org/10.1371/journal.pone.0192691.g001
Table 2. Summary of HR comparison data between Charge 2 and ECG.
Parameter
Fitbit Charge 2 Mean HR
(bpm)
Gold Standard ECG Mean HR
(bpm)
Mean Bias
(bpm)
95% Upper LoA
(bpm)
95% Lower
(bpm)
Intraclass Correlation Coefficient
(ICC)
102.7 (20.1) 109.8 (20.9) -5.9 (11.6) +16.8 -28.5 0.21
Standard deviations are presented in parentheses.
https://doi.org/10.1371/journal.pone.0192691.t002
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Discussion
The aim of the present study was to assess in a controlled research environment the accuracy
of the Fitbit Charge 2 for measuring HR. Our findings are in line with those of several recent
publications involving the predecessor of this device (i.e. Fitbit Charge HR). Aggregate mean
biases ranged from -2.5 bpm [21] to -9.3 bpm [10]. Wallen et al. [10], found the Fitbit Charge
HR to have the highest bias among other three activity monitors tested (i.e. Apple Watch, Sam-
sung Gear S, and Mio Alpha), reported an average error of -9.3 (± 8.5) bpm. Stahl et al. [16],
and also found the Fitbit Charge HR to have the greatest bias among other five fitness trackers
tested (Scosche Rhythm, Mio Alpha, TomTom Runner Cardio, Microsoft Band, Basis Peak).
The criterion measure (i.e. Polar RS400) had a mean of 109.06 (± 29.3) bpm, whereas the com-
piled means of the Fitbit Charge HR was 105.00 (± 30.6) bpm. Other studies [13,17,18] fall
within this range. The study by Cadmus-Bertram [21] was the one reporting the lower bias.
We believe this might be imputable to the fact that participants exercised at just 65% of the
maximum HR.
Fig 2. HR data (Fitbit Charge 2 vs. ECG). Bland-Altman Plot indicating mean difference in HR detection between the Charge 2 and ECG criterion measure. Mean
bias and Limits of Agreement (95% LoA) are shown.
https://doi.org/10.1371/journal.pone.0192691.g002
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Our results showed that the Charge 2 tends to underestimate the effective HR, with a bias
and lack of precision that are fairly consistent across the range of heart rates. Since those inac-
curacies occurred mainly during peaks of HR, it may be speculated that the current algorithms
for HR estimation lack proper sophistication (Fig 4).
According to Takacs et al. [5], inaccurate measures of physical activity can affect the ability
to monitor health status and are potentially dangerous for users. HR training relies in fact on
exercising in different HR zones, each of which is a percentage of your maximum HR: once
these are calculated, the workout can be tailored to the specific user, balancing fitness gain
without overloading the heart activity.
Unstable positioning of the device, movement of the wrist compared to the rest of the arm
and the whole body, variation in pressure of the sensor on the skin are the most plausible
causes for this frequent problem for wrist-worn devices. Although our experimental setting
was specifically built to control some of these issues, for 3 of 15 participants the Fitbit was not
able to continuously register data (with a maximum of 35% of data loss).
Fig 3. HR data with trend (Fitbit Charge 2 vs. ECG). Bland-Altman Plot modeling a trend over continuous heart rate indicating mean difference in HR detection
between the Charge 2 and ECG criterion measure. Mean bias and Limits of Agreement (95% LoA) are shown.
https://doi.org/10.1371/journal.pone.0192691.g003
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Fig 4. Representative time-series data of 5 participants (A, B, C, D, E).
https://doi.org/10.1371/journal.pone.0192691.g004
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Concerning the correlation between the position of the sensor and cycling activity, further
studies need to be carried out to reveal if this new model of Fitbit is less accurate during cycling
compared to walking or running activity. Studies performed on previous Fitbit models showed
that the Fitbit Surge performed better during cycling than during high HR walking and run-
ning sessions [22], while they confirmed inaccurate performances of the Fitbit Charge HR dur-
ing medium to higher intensity of activity, including low and intense cycling [13]. Since the
specific algorithm used by the Fitbit is protected, it is not possible to explain the origin of the
measurement discrepancies, and to discriminate if they are originated by software, firmware of
hardware.
Our understanding is that intrinsic differences exist between PPG and ECG methods that
calculate heart activity measuring different peaks and waveform of the heartbeat: specifically,
by PPG in general, P peaks are recorded, and P-P intervals are evaluated without including
high frequency components corresponding to heart beats; with an electrocardiogram instead,
the full PQRST wave is registered, the interval between R-peaks are usually used to quantify
the final HR. Inaccurate sampling and recording of the P peaks can definitely affect the final
calculation of the HR by PPG. Furthermore, while we know that the gold standard instrument
used in this study (i.e. PROCOMP Infiniti) extrapolates the complex HRV using an HRV reso-
nant frequency detection, and calculates standard deviations and root mean square of R-R
intervals, as well as the pNN50 values (i.e. percentage of pairs of adjacent P-P intervals differ-
ing by more than 50 ms), we do not know if the PurePulse technology relies on P-P or R-R
intervals and how the pulse intervals are detected.
Future work will be devoted to a complete evaluation of new HR monitors performances
and accuracy on a larger group of participants, including different skin characteristics, BMI
and ages. Further studies will compare the Fitbit Charge 2 with previous models and equiva-
lent wrist-worn devices on the market. The protocol for the evaluation of the performances
will include a defined activity pattern for the participants in order to simulate low, medium
and intensive exercise. The duration of these different training steps will allow the participant
to keep a constant heart rate activity and breath rate for prolonged periods of time. This will
allow the quantification of sampling efficiency for this technology, to identify strategies used
for the representation of the data, and to distinguish algorithmic artifacts from unreliable data.
Conclusions
The most recent Fitbit Charge 2 presents level of accuracy for HR measurement and perfor-
mances unchanged from existing models of the same brand. Whilst there is only moderate
bias on average, precision is poor for individual measurements, which could plausibly be
underestimated by as much as 30 bpm. Although the exact algorithm used by the Fitbit device
to estimate heart rate from the PPG measurements is not in the public domain, instability and
improper positioning of the device may potentially explain different results and poor-quality
HR data.
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